APA (7th ed.) Citation

Long, J., Dai, W., Zheng, Y., & Zhao, S. (2019). miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Molecular medicine (Cambridge, Mass.), 25(1), 26-13. https://doi.org/10.1186/s10020-019-0085-2

Chicago Style (17th ed.) Citation

Long, Jun-Ke, Wen Dai, Ya-Wen Zheng, and Shui-Ping Zhao. "MiR-122 Promotes Hepatic Lipogenesis via Inhibiting the LKB1/AMPK Pathway by Targeting Sirt1 in Non-alcoholic Fatty Liver Disease." Molecular Medicine (Cambridge, Mass.) 25, no. 1 (2019): 26-13. https://doi.org/10.1186/s10020-019-0085-2.

MLA (9th ed.) Citation

Long, Jun-Ke, et al. "MiR-122 Promotes Hepatic Lipogenesis via Inhibiting the LKB1/AMPK Pathway by Targeting Sirt1 in Non-alcoholic Fatty Liver Disease." Molecular Medicine (Cambridge, Mass.), vol. 25, no. 1, 2019, pp. 26-13, https://doi.org/10.1186/s10020-019-0085-2.